Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that increases platelet counts in patients with idiopathic thrombocytopenic purpura and in patients with liver cirrhosis. This evidence concerns the gene THPO and autoimmune thrombocytopenic purpura.